
There is a huge variation in cancer survival rates across the world, a global study shows.
The US, Australia, Canada, France and Japan had the highest five-year survival rates, while Algeria had the worst, Lancet Oncology reported. The UK faired pretty poorly, trailing most of its western European neighbours - although the data is from the 1990s since when survival rates have risen. Spending on health care was a major factor, the study of 31 countries said.
Researchers said higher spending often meant quicker access to tests and tThe research was carried out by more than 100 scientists across the world led by Professor Michel Coleman, of the London School of Hygiene and Tropical Medicine.
The US, Australia, Canada, France and Japan had the highest five-year survival rates, while Algeria had the worst, Lancet Oncology reported. The UK faired pretty poorly, trailing most of its western European neighbours - although the data is from the 1990s since when survival rates have risen. Spending on health care was a major factor, the study of 31 countries said.
Researchers said higher spending often meant quicker access to tests and tThe research was carried out by more than 100 scientists across the world led by Professor Michel Coleman, of the London School of Hygiene and Tropical Medicine.
It involved analysing data on more than two million cancer patients who were diagnosed and treated during the 1990s. The study showed the US had the highest five-year survival rates for breast cancer at 83.9% and prostate cancer at 91.9%. Japan came out best for male colon and rectal cancers, at 63% and 58.2% respectively, while France faired best for women with those cancers at 60.1% and 63.9%.
The UK had 69.7% survival for breast cancer, just above 40% for colon and rectal cancer for both men and women and 51.1% for prostate cancer. There were also large regional variations within the UK, which were linked to differences in access to care and ability of patients to navigate the local health services. Both are directly linked to deprivation. Algeria, the only African country involved, came bottom in all types of cancer.